There were 1,710 press releases posted in the last 24 hours and 406,171 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
ORYZON Announces First Patient Dosed in NCI-Sponsored Iadademstat in Combination With Venetoclax and Azacitidine Clinical Trial in First Line Acute Myeloid Leukemia

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.